Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of this work is to develop a strategy for derivatization of CS oligosaccharides to facilitate their sequencing and quantification using tandem mass spectrometry. A series of CID MS/MS spectra were acquired for CS oligosaccharides corresponding to degree of polymerization 2-8. CS-A is composed primarily of GlcA(1-3)3GalNAc-4-sulfate(1-4) and CS-C of GlcA(1-3)GalNAc-6-sulfate(1-4). CSB is composed of IdoA(1-3)GalNAc-4-sulfate(1-4). This project investigates the effects of reducing terminal derivatives on the information content of tandem mass spectra generated from these molecules. The cleanup step is of primary importance for these studies. Because glycosaminoglycans are sulfated, they have different chromatographic properties than do neutral oligosaccharides. In the past year, we have developed a workup scheme using microcrystalline cellulose spin filters that is proving to be extremely effective for cleaning up the derivatization mixtures. Although particulate microcrystalline cellulose is widely available, it has not been applied to the problem of reductive amination cleanup. CID MS/MS spectra for CS oligosaccharides reductively aminated with 2-anthranilic acid produced tandem mass spectra that were similar in general terms to those of native structures. The product ion patterns of labeled oligosaccharides derived from each of the three main classes of chondroitin sulfate generated from CS were then compared. The abundances of ions that differentiate the isomeric forms were found to be more abundant than those for the native structures. Thus, there appear to be analytical value in the derivatization scheme in terms of the product ion abundances.
No Sub Projects information available for 5P41RR010888-10 7075
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P41RR010888-10 7075
Patents
No Patents information available for 5P41RR010888-10 7075
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P41RR010888-10 7075
Clinical Studies
No Clinical Studies information available for 5P41RR010888-10 7075
News and More
Related News Releases
No news release information available for 5P41RR010888-10 7075
History
No Historical information available for 5P41RR010888-10 7075
Similar Projects
No Similar Projects information available for 5P41RR010888-10 7075